Nigeria continues to face an uphill battle against counterfeit drugs due to weak regulatory enforcement, legal loopholes, and corruption that undermine efforts to eliminate the crisis.
Despite ongoing crackdowns by authorities, the Nigerian pharmaceutical market remains flooded with fake and substandard medicines, endangering millions of lives.
NAFDAC’s Efforts and Persistent Challenges
Data from the National Agency for Food and Drug Administration and Control (NAFDAC) reveals significant actions taken in 2022 and 2023. Within this period:
- 1,125 illegal drug outlets were shut down.
- 62 unlicensed drug factories were dismantled.
- 108 warehouses filled with unapproved medical products were sealed.
- 412 individuals were arrested.
- Counterfeit drugs worth ₦21.1 billion were seized and destroyed.
While these efforts mark progress, they have not eradicated the issue. The World Health Organization (WHO) estimates that counterfeit medicines still account for 15-17% of drugs in circulation across Nigeria.
Dire Consequences of Counterfeit Drugs
Patients unknowingly consuming fake medications risk severe health complications, ineffective treatments, or even fatalities, worsening Nigeria’s already fragile healthcare system. The prevalence of counterfeit drugs undermines trust in medical treatment and places immense pressure on healthcare professionals.
Weak Legal Frameworks Undermining Progress
One of the biggest barriers to combating drug counterfeiting in Nigeria is the weak legal framework. Under current laws:
- Convicted counterfeiters face a maximum sentence of 15 years or a fine as low as ₦500,000—a negligible amount compared to the profits made from counterfeit drugs.
- NAFDAC’s Public Relations Officer, Christy Obiazikwor, has criticized these penalties, emphasizing that fines are too low to deter offenders effectively.
- Many cases remain stuck in the judicial system for years, with some unresolved since 2010.
Calls for Stronger Legal Action
To tackle these challenges, NAFDAC is pushing for stricter penalties, including:
- The death penalty for counterfeiters whose fake drugs lead to fatalities.
- Life imprisonment as proposed by Nigeria’s House of Representatives.
- Stronger enforcement mechanisms and reforms within the judicial system.
NAFDAC’s Director-General, Mojisola Adeyeye, has stressed the devastating impact of counterfeit drugs, stating: “You don’t need a gun to kill a child; bad medicine can do the job.” Lawmakers are urging the Attorney-General of the Federation, Lateef Fagbemi, to amend existing legislation to introduce harsher punishments.
Expert Opinions and Possible Solutions
Legal expert Suleiman Hassan Gimba, Managing Partner at Magna Legalese Limited, highlighted three primary obstacles to combating counterfeit drugs:
- Porous borders facilitating the smuggling of fake medicines.
- Corruption within regulatory agencies, weakening enforcement.
- Poor coordination between agencies, leading to ineffective crackdowns.
Gimba compared Nigeria’s penalties to those in China and India, where large-scale counterfeit drug operations attract life imprisonment or the death penalty. He recommended:
- Increasing fines beyond ₦500,000 to reflect the scale of the illegal trade.
- Asset forfeiture for convicted counterfeiters.
- Implementing advanced technologies like blockchain tracking, AI-powered drug detection, and enhanced border surveillance to curb the spread of fake medicines.
The Road Ahead
Despite years of effort, counterfeit drugs remain a major threat in Nigeria. While NAFDAC has stepped up enforcement and lawmakers are advocating for stricter sanctions, weak laws, corruption, and smuggling networks continue to fuel the illicit drug market. Strengthening legal frameworks, adopting innovative tracking technologies, and improving inter-agency collaboration are critical to winning the fight against counterfeit drugs in Nigeria.
READ ALSO:
Follow the LMSINT MEDIA channel on WhatsApp:
Join Our WhatsApp Group Hear:
Kindly Share:
Discover more from LMSINT STORE
Subscribe to get the latest posts sent to your email.
